THER — Theralink Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- $0.62m
- $23.20m
- $0.61m
Annual cashflow statement for Theralink Technologies, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.4 | -3.17 | -5.47 | -12.7 | -30.9 |
| Depreciation | |||||
| Non-Cash Items | 7.23 | -0.201 | -0.149 | 6.82 | 21.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.996 | -0.197 | 0.654 | 0.34 | 3.08 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.17 | -3.47 | -4.78 | -5.39 | -5.77 |
| Capital Expenditures | — | -0.532 | -0.136 | -0.132 | -0.163 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.676 | 0.002 | 0 | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | 0.144 | -0.134 | -0.132 | -0.163 |
| Financing Cash Flow Items | — | -0.02 | — | -0.027 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.19 | 4.55 | 3.45 | 5.6 | 6.54 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.021 | 1.22 | -1.47 | 0.079 | 0.604 |